Amine Kamen
Affiliations: | Universite Laval (Canada) |
Area:
Chemical Engineering, Microbiology BiologyGoogle:
"Amine Kamen"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Silva CAT, Kamen AA, Henry O. (2024) Fed-batch strategies for intensified rVSV vector production in high cell density cultures of suspension HEK293 cells. Biotechnology Progress. e3506 |
Göbel S, Pelz L, Silva CAT, et al. (2024) Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology. 108: 240 |
Silva CAT, Kamen AA, Henry O. (2023) Intensified Influenza Virus Production in Suspension HEK293SF Cell Cultures Operated in Fed-Batch or Perfusion with Continuous Harvest. Vaccines. 11 |
Sène MA, Xia Y, Kamen AA. (2023) Comparative Transcriptomic Analyses of a Vero Cell Line in Suspension versus Adherent Culture Conditions. International Journal of Cell Biology. 2023: 9364689 |
Moço PD, Xu X, Silva CAT, et al. (2023) Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities. Biotechnology Journal. e2300051 |
Dash S, Farnós O, Yang Z, et al. (2023) A rapid procedure to generate stably transfected HEK293 suspension cells for recombinant protein manufacturing: Yield improvements, bioreactor production and downstream processing. Protein Expression and Purification. 210: 106295 |
Sène MA, Xia Y, Kamen AA. (2022) From functional genomics of vero cells to CRISPR-based genomic deletion for improved viral production rates. Biotechnology and Bioengineering |
Tran MY, Kamen AA. (2022) Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing. Frontiers in Bioengineering and Biotechnology. 10: 887716 |
Dash S, Sharon DM, Mullick A, et al. (2022) Only a small fraction of cells produce assembled capsids during transfection-based manufacturing of adeno-associated virus vectors. Biotechnology and Bioengineering |
Fulber JPC, Farnós O, Kiesslich S, et al. (2021) Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures. Vaccines. 9 |